腹部脑脊液假性囊肿治疗后分流管腹腔再置入:24年单中心经验
腹腔镜与迷你开腹再置入后1年全因分流存活率分别为58.4%和42.9%。
要点
- 腹部脑脊液假性囊肿是儿童脑室腹腔分流罕见并发症,囊液培养阳性率67%。
- 经治疗后的腹腔再置入可行,71%患儿无假性囊肿复发。
- 腹腔镜与迷你开腹再置入的1年无复发存活率相近(84.7% vs 85.7%)。
核心结论
- 对腹部脑脊液假性囊肿治疗后,选择性患儿行分流管腹腔再置入可行,本队列多数患儿避免复发。
研究设计与样本
- 采用Kaplan-Meier生存分析比较腹腔镜与迷你开腹腹腔再置入后的分流存活。
主要发现
- 诊断时平均年龄13岁。
- 再置入后1年全因分流存活率:腹腔镜组58.4%,迷你开腹组42.9%。
- 1年无假性囊肿复发存活率:腹腔镜组84.7%,迷你开腹组85.7%。
临床怎么用
- 对腹部脑脊液假性囊肿治疗后的选择性患儿,可考虑分流管腹腔再置入以恢复腹腔吸收。
- 腹腔镜辅助远端导管置入可作为腹腔再置入的术式选择之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Abdominal cerebrospinal fluid (CSF) pseudocyst is a rare complication of ventriculoperitoneal shunt placement in children preventing adequate absorption of CSF in the peritoneum. This study describes a 24-year single-institution experience with management of abdominal CSF pseudocysts, with special attention to peritoneal re-internalization and laparoscopic-assisted distal catheter placement. METHODS: We performed a retrospective analysis of patients with hydrocephalus presenting with CSF pseudocyst between January 1, 2000- December 1, 2024. Diagnosis was confirmed by ultrasound or computed tomography. Kaplan-Meier survival analysis was used to compare shunt survival after laparoscopic and mini-laparotomy peritoneal re-internalization. RESULTS: Twenty-seven patients were treated for CSF pseudocyst over 24 years, and 18 had culture-positive pseudocyst fluid (67%). The average age at diagnosis was 13 years old. Twenty-one children underwent peritoneal re-implantation, and 15 (71%) children did not have pseudocyst recurrence. At one year after re-internalization, all cause shunt-survival was 58.4%, following laparoscopic placement compared with 42.9% following mini-laparotomy. One-year pseudocyst recurrence-free survival was 84.7% and 85.7%, respectively. CONCLUSION: Peritoneal shunt re-internalization was feasible in selected patients after treatment of abdominal CSF pseudocyst, with most patients in this cohort avoiding recurrence. These findings support further multicenter study.
引用
- Puglisi EN, Desai D, Staffa S, et al. Peritoneal re-internalization of shunts after pseudocyst treatment: a 24-year single institution experience. World Neurosurg. 2026. PMID: 42933726. doi:10.1016/j.wneu.2026.125445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。